• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    BioNexus Gene Lab Corp - Common stock (NQ:BGLC)

    2.460 -0.030 (-1.20%)
    Streaming Delayed Price Updated: 9:31 AM EDT, Mar 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about BioNexus Gene Lab Corp - Common stock

    News headline image
    BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.
    Collaboration Expected to Advance FS2 Topical Platform and Strengthen BGLC’s Biotech Footprint in Asia 
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    Mag 7 Undercard: REPL, BGLC, TYGO, SGD – More Stocks Inside Heating Up Now!
    Via AB Newswire
    Topics Economy
    News headline image
    BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    News headline image
    BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
    From BioNexus Gene Lab Corp.
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.